A detailed history of Fny Investment Advisers, LLC transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Fny Investment Advisers, LLC holds 176,754 shares of DNA stock, worth $1.44 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
176,754
Previous 112,014 57.8%
Holding current value
$1.44 Million
Previous $129,000 54.26%
% of portfolio
0.04%
Previous 0.08%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

BUY
$0.28 - $1.16 $18,127 - $75,098
64,740 Added 57.8%
176,754 $59,000
Q1 2024

May 02, 2024

SELL
$1.06 - $1.67 $10,366 - $16,332
-9,780 Reduced 8.03%
112,014 $129,000
Q4 2023

Jan 12, 2024

BUY
$1.26 - $1.79 $75 - $107
60 Added 0.05%
121,794 $205,000
Q3 2023

Oct 10, 2023

BUY
$1.61 - $2.54 $128 - $203
80 Added 0.07%
121,734 $220,000
Q2 2023

Jul 11, 2023

BUY
$1.14 - $1.95 $28,499 - $48,750
25,000 Added 25.87%
121,654 $226,000
Q1 2023

Apr 12, 2023

SELL
$1.2 - $2.19 $9,120 - $16,644
-7,600 Reduced 7.29%
96,654 $128,000
Q4 2022

Jan 10, 2023

BUY
$1.63 - $3.52 $51,468 - $111,147
31,576 Added 43.45%
104,254 $176,000
Q3 2022

Oct 19, 2022

SELL
$0.73 - $3.74 $21,901 - $112,207
-30,002 Reduced 29.22%
72,678 $226,000
Q2 2022

Jul 12, 2022

BUY
$2.2 - $4.2 $33,836 - $64,596
15,380 Added 17.62%
102,680 $244,000
Q1 2022

Apr 25, 2022

BUY
$2.83 - $8.69 $225,381 - $692,071
79,640 Added 1039.69%
87,300 $351,000
Q4 2021

Jan 10, 2022

SELL
$8.31 - $14.92 $350,100 - $628,579
-42,130 Reduced 84.62%
7,660 $63,000
Q3 2021

Oct 13, 2021

BUY
$9.15 - $13.28 $455,578 - $661,211
49,790 New
49,790 $577,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $10.5B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Fny Investment Advisers, LLC Portfolio

Follow Fny Investment Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fny Investment Advisers, LLC with notifications on news.